Morgan Stanley Maintains Zoetis(ZTS.US) With Buy Rating, Maintains Target Price $248

Morgan Stanley analyst Erin Wright maintains $Zoetis(ZTS.US)$ with a buy rating, and maintains the target price at $248.According to TipRanks data, the analyst has a success rate of 65.4% and a total

Futu NewsJun 28 20:31 · Ratings

Express News | Lifecome Biochemistry: signed a supply agreement with Solvay Belgium.

BreakingsJun 28 19:56

10 Health Care Stocks Whale Activity In Today's Session

This whale alert can help traders discover the next big trading opportunities.

BenzingaJun 27 01:35

Global Veterinary Pain Management Market Report 2024-2032, Featuring Assisi Animal Health, Bayer, Chanelle Pharma, Dechra Pharmaceuticals, Eli Lilly, Idexx Laboratories, Norbrook, Vetoquinol & Zoetis

Yahoo FinanceJun 24 22:35

Here's Why Zoetis (NYSE:ZTS) Can Manage Its Debt Responsibly

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously said that 'Volatility is far from synonymous with risk.' It's only natural to co

Simply Wall StJun 23 20:52

Is Zoetis Stock Underperforming the Nasdaq?

BarchartJun 20 21:45